|
Diabetes, Vol 37, Issue 8 1025-1034, Copyright © 1988 by American Diabetes Association
Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps
DT Finegood, RN Bergman and M Vranic
Department of Physiology, University of Toronto, Ontario, Canada.
We previously demonstrated that conventional tracer methods applied to
euglycemic-hyperinsulinemic glucose clamps result in substantially negative
estimates for the rate of endogenous glucose production, particularly
during the first half of 180-min clamps. We also showed that addition of
tracer to the exogenous glucose infusate resulted in nonnegative endogenous
glucose production (Ra) estimates. In this study, we investigated the
underlying cause of negative estimates of Ra from conventional clamp/tracer
methods and the reason for the difference in estimates when tracer is added
to the exogenous glucose infusate. We performed euglycemic-hyperinsulinemic
(300-microU/ml) clamps in normal dogs without (cold GINF protocol, n = 6)
or with (hot GINF protocol, n = 6) tracer (D-[3-3H]glucose) added to the
exogenous glucose infusate. In the hot GINF protocol, sufficient tracer was
added to the exogenous glucose infusate such that arterial plasma specific
activity (SAa) did not change from basal through the clamp period (P
greater than .05). In the cold GINF studies, plasma SAa fell 81 +/- 2% from
the basal level by the 3rd h of clamping. We observed a significant,
transient, positive venous-arterial difference in specific activity
(SAv-SAa difference) during the cold GINF studies. The SAv-SAa difference
reached a peak of 27 +/- 6% at 30 min and diminished to a plateau of 7 +/-
1% between 70 and 180 min. We also observed a positive but constant SAv-SAa
difference (4.6 +/- 0.2% between 10 and 180 min) during the hot GINF
studies. The observations of a difference between hot and cold GINF
endogenous Ra estimates and a positive but transient SAv-SAa difference
during the cold GINF studies are consistent with the interpretation that a
portion of the underestimation of Ra is due to insufficient mixing of
endogenous and exogenous glucose for the one-compartment, fixed-pool volume
model to be applicable. Alternatively, our results suggest that the
one-compartment, fixed-pool volume model of glucose kinetics is
insufficient to account for the complex dynamics of labeled and unlabeled
glucose during euglycemic-hyperinsulinemic clamps. Improved mixing through
addition of tracer to the exogenous glucose infusate or improved modeling
by allowing for a variable-pool volume appears to improve the accuracy of
the tracer methods; however, these approaches remain to be validated. The
constant positive SAv-SAa difference observed during the hot GINF studies
is consistent with the interpretation that an additional contributor to
underestimation of endogenous Ra is apparent isotope
discrimination.(ABSTRACT TRUNCATED AT 400 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. R. Lanza, D. K. Short, K. R. Short, S. Raghavakaimal, R. Basu, M. J. Joyner, J. P. McConnell, and K. S. Nair
Endurance Exercise as a Countermeasure for Aging
Diabetes,
November 1, 2008;
57(11):
2933 - 2942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Park, V. Wong, X. Guan, A. I Oprescu, and A. Giacca
Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo
J. Endocrinol.,
November 1, 2007;
195(2):
323 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Carpentier, F. Frisch, P. Brassard, F. Lavoie, A. Bourbonnais, D. Cyr, R. Giguere, and J.-P. Baillargeon
Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans
Am J Physiol Endocrinol Metab,
March 1, 2007;
292(3):
E693 - E701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ozawa, M. Miyazaki, M. Matsuhisa, K. Takano, Y. Nakatani, M. Hatazaki, T. Tamatani, K. Yamagata, J.-i. Miyagawa, Y. Kitao, et al.
The Endoplasmic Reticulum Chaperone Improves Insulin Resistance in Type 2 Diabetes
Diabetes,
March 1, 2005;
54(3):
657 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Thorell, O. Rooyackers, P. Myrenfors, M. Soop, J. Nygren, and O. H. Ljungqvist
Intensive Insulin Treatment in Critically Ill Trauma Patients Normalizes Glucose by Reducing Endogenous Glucose Production
J. Clin. Endocrinol. Metab.,
November 1, 2004;
89(11):
5382 - 5386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza
Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes
Diabetes,
August 1, 2004;
53(8):
2042 - 2050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Camacho, D. B. Lacy, F. D. James, R. H. Coker, and D. H. Wasserman
Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose
Am J Physiol Endocrinol Metab,
August 1, 2004;
287(2):
E269 - E274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Camacho, R. R. Pencek, D. B. Lacy, F. D. James, and D. H. Wasserman
Suppression of Endogenous Glucose Production by Mild Hyperinsulinemia During Exercise Is Determined Predominantly by Portal Venous Insulin
Diabetes,
February 1, 2004;
53(2):
285 - 293.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. L. Simpson, N. C. Jackson, F. Shojaee-Moradie, R. H. Jones, D. L. Russell-Jones, P. H. Sonksen, D. B. Dunger, and A. M. Umpleby
Insulin-Like Growth Factor I Has a Direct Effect on Glucose and Protein Metabolism, But No Effect on Lipid Metabolism in Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
January 1, 2004;
89(1):
425 - 432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vella, A. S. Reed, N. Charkoudian, P. Shah, R. Basu, A. Basu, M. J. Joyner, and R. A. Rizza
Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles
Am J Physiol Endocrinol Metab,
July 1, 2003;
285(1):
E25 - E30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, B. Di Camillo, G. Toffolo, A. Basu, P. Shah, A. Vella, R. Rizza, and C. Cobelli
Use of a novel triple-tracer approach to assess postprandial glucose metabolism
Am J Physiol Endocrinol Metab,
January 1, 2003;
284(1):
E55 - E69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gupta, H. Sandhu, T. Goh, K. Shah, S. R. Wiesenthal, H. Yoshii, V. Chong, T. K. T. Lam, C. A. Haber, W. Williams, et al.
Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia
Am J Physiol Endocrinol Metab,
November 1, 2002;
283(5):
E1002 - E1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Musi, M. F. Hirshman, J. Nygren, M. Svanfeldt, P. Bavenholm, O. Rooyackers, G. Zhou, J. M. Williamson, O. Ljunqvist, S. Efendic, et al.
Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes
Diabetes,
July 1, 2002;
51(7):
2074 - 2081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev.,
April 1, 2002;
23(2):
201 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Meneilly, C. H.S. McIntosh, R. A. Pederson, J. F. Habener, R. Gingerich, J. M. Egan, D. T. Finegood, and D. Elahi
Effect of Glucagon-Like Peptide 1 on Non-Insulin-Mediated Glucose Uptake in the Elderly Patient With Diabetes
Diabetes Care,
November 1, 2001;
24(11):
1951 - 1956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Edgerton, S. Cardin, M. Emshwiller, D. Neal, V. Chandramouli, W. C. Schumann, B. R. Landau, L. Rossetti, and A. D. Cherrington
Small Increases in Insulin Inhibit Hepatic Glucose Production Solely Caused by an Effect on Glycogen Metabolism
Diabetes,
August 1, 2001;
50(8):
1872 - 1882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, M. Jensen, K. S. Nair, W. F. Schwenk, and R. A. Rizza
Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding: Additional Evidence for a Defect in Hepatic Glucokinase Activity
Diabetes,
June 1, 2001;
50(6):
1351 - 1362.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Carpentier, B. W. Patterson, K. D. Uffelman, A. Giacca, M. Vranic, M. S. Cattral, and G. F. Lewis
The Effect of Systemic Versus Portal Insulin Delivery in Pancreas Transplantation on Insulin Action and VLDL Metabolism
Diabetes,
June 1, 2001;
50(6):
1402 - 1413.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. N. Båvenholm, J. Pigon, C.-G. Östenson, and S. Efendic
Insulin Sensitivity of Suppression of Endogenous Glucose Production Is the Single Most Important Determinant of Glucose Tolerance
Diabetes,
June 1, 2001;
50(6):
1449 - 1454.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Soop, J. Nygren, P. Myrenfors, A. Thorell, and O. Ljungqvist
Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance
Am J Physiol Endocrinol Metab,
April 1, 2001;
280(4):
E576 - E583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Thresher, D. A. Podolin, Y. Wei, R. S. Mazzeo, and M. J. Pagliassotti
Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2000;
279(4):
R1334 - R1340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gastaldelli, A. R. Coggan, and R. R. Wolfe
Assessment of methods for improving tracer estimation of non-steady-state rate of appearance
J Appl Physiol,
November 1, 1999;
87(5):
1813 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bergeron, M. Kjaer, L. Simonsen, J. Bulow, and H. Galbo
Glucose production during exercise in humans: a-hv balance and isotopic-tracer measurements compared
J Appl Physiol,
July 1, 1999;
87(1):
111 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Thorell, J. Nygren, M. F. Hirshman, T. Hayashi, K. S. Nair, E. S. Horton, L. J. Goodyear, and O. Ljungqvist
Surgery-induced insulin resistance in human patients: relation to glucose transport and utilization
Am J Physiol Endocrinol Metab,
April 1, 1999;
276(4):
E754 - E761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Lewis, A. Carpentier, D. Bilinski, A. Giacca, and M. Vranic
Counterregulatory Response to Hypoglycemia Differs According to the Insulin Delivery Route, But Does Not Affect Glucose Production in Normal Humans
J. Clin. Endocrinol. Metab.,
March 1, 1999;
84(3):
1037 - 1046.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. W. Coppack, M. Persson, R. L. Judd, and J. M. Miles
Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo
Am J Physiol Endocrinol Metab,
February 1, 1999;
276(2):
E233 - E240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cersosimo, P. Garlick, and J. Ferretti
Insulin regulation of renal glucose metabolism in humans
Am J Physiol Endocrinol Metab,
January 1, 1999;
276(1):
E78 - E84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Wise, M. F. Nielsen, P. E. Cryer, and R. A. Rizza
Overnight Normalization of Glucose Concentrations Improves Hepatic But Not Extrahepatic Insulin Action in Subjects with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
July 1, 1998;
83(7):
2461 - 2469.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. O. Nygren, A. Thorell, M. Soop, S. Efendic, K. Brismar, F. Karpe, K. S. Nair, and O. Ljungqvist
Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery
Am J Physiol Endocrinol Metab,
July 1, 1998;
275(1):
E140 - E148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Lewis, M. Vranic, and A. Giacca
Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans
Am J Physiol Endocrinol Metab,
July 1, 1998;
275(1):
E177 - E186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. McCall, S. R. Wiesenthal, Z. Q. Shi, K. Polonsky, and A. Giacca
Insulin acutely suppresses glucose production by both peripheral and hepatic effects in normal dogs
Am J Physiol Endocrinol Metab,
February 1, 1998;
274(2):
E346 - E356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-A. Simoneau and D. E. Kelley
Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM
J Appl Physiol,
July 1, 1997;
83(1):
166 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Giacca, S. J. Fisher, R. H. McCall, Z. Q. Shi, and M. Vranic
Direct and Indirect Effects of Insulin in Suppressing Glucose Production in Depancreatized Dogs: Role of Glucagon
Endocrinology,
March 1, 1997;
138(3):
999 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1988 by the American Diabetes Association.
|
|
| |
|